Degrado TR - Search Results

1

Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.

Beauregard JM, Williams SG, Degrado TR, Roselt P, Hicks RJ. Beauregard JM, et al. Among authors: degrado tr. J Med Imaging Radiat Oncol. 2010 Aug;54(4):325-32. doi: 10.1111/j.1754-9485.2010.02178.x. J Med Imaging Radiat Oncol. 2010. PMID: 20718912

2

Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.

Price DT, Coleman RE, Liao RP, Robertson CN, Polascik TJ, DeGrado TR. Price DT, et al. Among authors: degrado tr. J Urol. 2002 Jul;168(1):273-80. J Urol. 2002. PMID: 12050555

3

Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.

Bansal A, Shuyan W, Hara T, Harris RA, Degrado TR. Bansal A, et al. Among authors: degrado tr. Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1192-203. doi: 10.1007/s00259-008-0736-y. Epub 2008 Feb 9. Eur J Nucl Med Mol Imaging. 2008. PMID: 18264706 Free PMC article.

4

Fluoromethylcholine PET in recurrent multifocal hepatoma.

Lenzo NP, Anderson J, Campbell A, Morandeau L, De Grado TR. Lenzo NP, et al. Australas Radiol. 2007 Dec;51 Suppl:B299-302. doi: 10.1111/j.1440-1673.2007.01802.x. Australas Radiol. 2007. PMID: 17991090

5

First PET Imaging Studies With 63Zn-Zinc Citrate in Healthy Human Participants and Patients With Alzheimer Disease.

DeGrado TR, Kemp BJ, Pandey MK, Jiang H, Gunderson TM, Linscheid LR, Woodwick AR, McConnell DM, Fletcher JG, Johnson GB, Petersen RC, Knopman DS, Lowe VJ. DeGrado TR, et al. Mol Imaging. 2016 Dec 9;15:1536012116673793. doi: 10.1177/1536012116673793. Print 2016. Mol Imaging. 2016. PMID: 27941122 Free PMC article.

6

Cancer imaging with fluorine-18-labeled choline derivatives.

Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Kwee SA, et al. Among authors: degrado tr. Semin Nucl Med. 2007 Nov;37(6):420-8. doi: 10.1053/j.semnuclmed.2007.07.003. Semin Nucl Med. 2007. PMID: 17920349 Review.

7

Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels.

Kwee SA, DeGrado T. Kwee SA, et al. Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1567-9; author reply 1570. doi: 10.1007/s00259-008-0781-6. Eur J Nucl Med Mol Imaging. 2008. PMID: 18521597 No abstract available.

8

Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells.

Hara T, Bansal A, DeGrado TR. Hara T, et al. Among authors: degrado tr. Nucl Med Biol. 2006 Nov;33(8):977-84. doi: 10.1016/j.nucmedbio.2006.08.002. Epub 2006 Oct 4. Nucl Med Biol. 2006. PMID: 17127170

9

Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.

DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, Polascik TJ, Price DT. DeGrado TR, et al. Cancer Res. 2001 Jan 1;61(1):110-7. Cancer Res. 2001. PMID: 11196147

10

Choline transporter as a novel target for molecular imaging of cancer.

Hara T, Bansal A, DeGrado TR. Hara T, et al. Among authors: degrado tr. Mol Imaging. 2006 Oct-Dec;5(4):498-509. Mol Imaging. 2006. PMID: 17150162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page